GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Select your language of interest to view the total content in your interested language
All manuscripts must be in English (and in MS Word format) and should be submitted via our online system. For submission of your research/review article, send as an e-mail attachment to the Editorial Office at [email protected]
Each manuscript must be accompanied by a cover letter signed by the corresponding author on behalf of all the authors. The cover letter should explicitly state that the manuscript has not been previously published in any language any where and that it is not under simultaneous consideration by another journal.
Copy Right Transfer:Download Copy Right
Submission of a review or research article to the journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere. Authors would be required to sign a form (to be supplied by the Editor) transferring copyright before the manuscript can be published.
Ethics in Animal and Clinical Investigation:
Investigation using experimental animals must state in the methods section that the research must be according to the OECD guidelines and must mention the protocol number of IAEC (Institutional animal ethics committee). Investigations with human subjects must state in the method section that the research followed the tenets of the declaration of Helsinki promulgated in 1964 and was approved by the Institutional Human Experimentation committee or equivalent, and that informed consent was obtained.
Reviews are written by researchers of considerable experience in the field concerned. The authors should review the recent trends or advances in that field in the light of their own work. The major portion of the above articles should deal with the up-to-date developments in the field in the last 3-5 years. Authors are advised to search medline and other databases on the internet, apart from collecting information using conventional methods.
These articles should contain a covering letter, title page, summary (need not be structured) and key words. They should be written under appropriate sub-headings. The authors are encouraged to use flowcharts, boxes, cartoons, tables and figures for better presentation.
Original Research Articles:
These may either be a full length research article. These papers should be arranged into the following sections:
1) Covering Letter
In addition to the general details (name, address, contact details including mobile number of the corresponding author), it should mention in brief what is already known about this subject and what new is added by the submitted work.
2) Title page
It should be paginated as page 1 of the paper. It should include the title, authors’ names and affiliations, running title, address for correspondence including e-mail address and also the total number of pages, figures and tables.
Must be informative, specific and short. It should not exceed 150 characters.
Authors and affiliations:
The names of authors and their affiliations should be given. It should be made clear which address relates to which author.
It is a short title printed in the journal at the right top corner of right hand page of the article (except the lead page). It should be not more than 50 characters in length.
Address for correspondence:
The corresponding author’s address should be given on the title page. The e-mail ID of the corresponding author or the contact e-mail ID must also be provided.
3) Abstract and keywords
It must start on a new page carrying the following information: (a) Title (without authors’ names or affiliations), (b) Abstract, (c) Key words, (d) Running title. It should not exceed 250 words excluding the title and the key words. The abstract must be concise, clear and informative rather than indicative.
The abstract must be in astructured form (OBJECTIVES, METHODS, RESULTS and CONCLUSIONS) and explain briefly what was intended, done, observed and concluded. The conclusions and recommendations not found in the text of the article should not be given in the abstract.
Provide 3-5 keywords which will help readers or indexing agencies in cross-indexing the study. The words found in title need not be given as key words. Use terms from the latest Medical Subject Headings (MeSH) list of Index Medicus. A more general term may be used if a suitable MeSH term is
It should start on a new page. Essentially this section must introduce the subject and briefly say how the idea for research originated. Give a concise background of the study. Do not review literature extensively but provide the most recent work that has a direct bearing on the subject. Justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end.
5) Materials and Methods:
This section should deal with the materials used and the methodology (how the work was carried out). The procedure adopted should be described in sufficient details to allow the experiment to be interpreted and repeated by the readers, if desired. The number of subjects, the number of groups, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The data collection procedure must be described. If a procedure is a commonly used, giving a previously published reference would suffice. If a method is not well known (though previously published) it is better to describe it briefly. Give explicit descriptions of modifications or new methods so that the readers can judge their accuracy,
Reproducibility and reliability.
The nomenclature, the source of material and equipment used, with details of the manufacturer in parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their non-proprietary names or generic names. If necessary, the proprietary or commercial name may be inserted once in parentheses. The first letter of the drug name should be small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., Persantin, Inderal). New or uncommon drug should be identified by the chemical name and structural formula.
The doses of drugs should be given as unit weight per kilogram body weight e.g., mg/kg and the concentrations should be given in terms of molarity e.g., nm or mM. The routes of administration may be abbreviated, e.g., intra-arterial (i.a.), intracerebroventricular (i.c.v.), intra-gastric gavage (i.g.), intramuscular (i.m.), intraperitoneal (i.p.), intravenous (i.v.), per os (p.o.), subcutaneous (s.c.),
Transdermal (t.d.) etc.
Statistical Methods: The variation of data should be expressed in terms of the standard error of mean (SEM) or the standard deviation (SD), along with the number of observations (n). The details of statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test.
The results should be stated concisely without comments. They should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables. Avoid
discussion and conclusion in the result section.
This section should deal with the interpretation, rather than recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth.
Avoid unqualified statements and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided. Conclusions must be drawn considering the strengths and weaknesses of the study. They must be conveyed in the last paragraph under Discussion. Make sure conclusions drawn should tally with the objectives stated under introduction.
These should be typed on a new page. Acknowledge only those who have contributed to the scientific content or provided technical support. Sources of financial support may be mentioned.
It should begin on a new page. The number of references should normally be restricted to a maximum of 25 for a full paper. Papers which have been submitted and accepted but not yet published may be included in the list of references with the name of the journal and indicated as “In press”. A photocopy of the acceptance letter should be submitted with the manuscript. Information from manuscript “submitted” but “not yet accepted” should not be included. Avoid using abstracts as references. The “unpublished observations” and “personal communications” may
not be used as references but may be inserted (in parentheses in the text.)
References are to be cited in the text by superscripted number and should be in the order in which they appear. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration. As far as possible mentioning names of author(s) for reference should be avoided in the text. Use the style of the examples below for writing references:
Singh VK: “A Text Book of Numerical Chemistry”, CBS Publishers & Distributors, New Delhi, Edition Ist , 2005.
The references must be verified by the author(s) against the original documents.
Tables should be cited consecutively in the text. Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used.
Check list for Tables
Each figure must be numbered and a short descriptive caption must be provided. A computer drawn figure with good contrast is acceptable. Sometimes, raw data for graphs may be required in Excel sheet when the article is accepted for publication. Graphic files for diagrams and figures may be converted to *.pcx, *.tiff, *.jpg format. These files should not exceed 2 MB in size.
Check list for Figures
PAPER LAYOUT DETAILS:
The details about page setup and manuscript layout are as follows:
Top = 0.5, Bottom = 0.5, Left = 0.5, Right = 0.5, Gutter = 0,Gutter Position = Left
A4 (8.27” x 11.69”)
Space within a paragraph
Manuscript layout details:
Title Case + Bold
Normal + Bold
Normal + Bold + Underline
Tw Cen MT
Normal + Bold
Abstract Body Text
Tw Cen MT
Tw Cen MT
Normal + Bold
Tw Cen MT
Tw Cen MT
Normal + Bold
Tw Cen MT
Normal + Bold + Italic
Tw Cen MT
Tw Cen MT
The authors should revise the manuscript immediately after receipt of the comments from the IJRDPL. A note mentioning the changes incorporated in the revised text as per referee’s comments (point by point) should be sent. The revised manuscript has to be submitted online within the stipulated time. Calling for revision does not guarantee acceptance. A revised manuscript which underwent major changes is likely to be sent to referees for re-review. If the authors have substantial reasons that their manuscript was rejected unjustifiably, they may request for reconsideration.
Proofs will be sent to the corresponding author for final checking. It is the authors’ responsibility to go through the proof meticulously and correct errors if any. Corrections should be restricted to printer’s error only and no substantial addition/deletion should be made.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Article Processing Charges (APC):
The author is liable to pay following publication charges:
Article Submission : 0.00 (INR)
Review cost : 0.00 (INR)
If this paper is accepted for publication, you will be informed at your email id to pay following charges as per the nature of manuscript
Average Article prorcessing time (APT) is 50 daysFast Editorial Execution and Review Process (FEE-Review Process):
Advances in Cancer Prevention is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals